Latest News
We Are Making Progress on AIDS
In an opinion piece published in the Wall Street Journal, IAVI President and CEO Seth Berkley challenges the pessimism surrounding recent AIDS vaccine media coverage and states that there are sound scientific reasons to believe we can create a vaccine against AIDS.
New Market Tax Credit Helps Finance IAVI AIDS Vaccine Development Lab Construction
The National Community Fund I, LLC and Greystone CDE, LLC have chosen IAVI’s new AIDS Vaccine Development Laboratory to be the recipient of a New Markets Tax Credit, a financing program designed to spur investment in businesses and create jobs in low-income communities.
IAVI and CHAVI Team Up on AIDS Vaccine Development
The Center for HIV/AIDS Vaccine Immunology has partnered with IAVI to research four key biological questions hindering the development of an AIDS vaccine.
A Cup of Science, Anyone?
Professor Omu Anzala, director of the Kenya AIDS Vaccine Initiative, will host Kenya’s first-ever Science Cafe on 17 April in a Nairobi coffee house.
U.S. NIH Sponsors AIDS Vaccine Summit
On March 25, the U.S. National Institutes of Health gathered leaders in HIV vaccine research and development to evaluate the current state of the AIDS vaccine field and determine a course for the future.
Latest AIDS Prevention News
A male circumcision study indicates no HIV-protection for women; another indicates reduction in genital infections. Two herpes suppression trials show treating genital herpes doesn’t reduce risk of HIV infection.
|